The use of semaglutide in patients with diabetes was associated with a significantly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) compared with those taking drugs for diabetes that belong to other classes of medication. http://ms.spr.ly/63322qY6Fy
Comments